GLENMARK PHARMACEUTICALS LTD. - Cancellation of Stock Options
28 Jan 2016
Glenmark Pharmaceuticals Ltd has informed BSE that the Nomination and Remuneration Committee of the Company, at its meeting held on January 28, 2016 has cancelled 34,500 stock options pursuant to ESOS 2003.
Source:
BSE India